DnB Asset Management
PRME icon

DnB Asset Management’s Prime Medicine PRME Stock Holding History

DnB Asset Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-182,133
Closed -$1.01M – 762
2025
Q3 		$1.01M Buy
+182,133
New +$740K ﹤0.01% 637

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

DnB Asset Management's PRME Position: Q4 2025 in Review

DnB Asset Management sold out of Prime Medicine (PRME) in Q4 2025, closing a stake of 182,133 shares — an estimated $1.01M sold.

DnB Asset Management first reported a position in PRME in Q3 2025 and held it in 1 quarter. The position peaked at $1.01M in Q3 2025. 183 funds tracked by Wall St. Rank hold PRME as of Q4 2025.

  • DnB Asset Management reported no remaining Prime Medicine position as of Q4 2025 after selling out during the quarter.
  • DnB Asset Management sold 182,133 Prime Medicine shares in Q4 2025, an estimated $1.01M.
  • DnB Asset Management first reported a position in Prime Medicine in Q3 2025 and held it in 1 quarter.
  • DnB Asset Management's Prime Medicine position peaked at $1.01M in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Prime Medicine as of Q4 2025.

Based on DnB Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.